1) The provider shall review the various aspects of the total drug dispensing system of HSH. These reviews will be designed to monitor and safeguard all areas of the drug dispensing system in order to assure safe and rational drug therapy to the patients and to determine the quality and storage of drugs used at HSH. 2) The provider will have an internal self-auditing program that will be shared with HSH leadership on a quarterly basis. This will assist HSH and the provider to reduce costs and take a proactive measure in ensuring sustainability for the program. In addition, drugs will be purchased directly from wholesalers rather than through the pharmacy vendor to streamline operations, errors, and lower costs by participating in the 340-B program.
